Monsanto Co. (MON) to Issue Quarterly Dividend of $0.54 on October 28th
Monsanto Co. (NYSE:MON) announced a quarterly dividend on Friday, August 12th. Stockholders of record on Friday, October 7th will be paid a dividend of 0.54 per share on Friday, October 28th. This represents a $2.16 annualized dividend and a dividend yield of 2.12%. The ex-dividend date is Wednesday, October 5th.
Shares of Monsanto (NYSE:MON) opened at 101.79 on Friday. Monsanto has a 12 month low of $83.73 and a 12 month high of $114.26. The firm has a market cap of $44.54 billion, a price-to-earnings ratio of 44.80 and a beta of 1.24. The stock has a 50 day moving average of $105.24 and a 200 day moving average of $100.93.
Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, June 29th. The company reported $2.17 earnings per share for the quarter, missing the consensus estimate of $2.40 by $0.23. The company had revenue of $4.19 billion for the quarter, compared to analysts’ expectations of $4.49 billion. Monsanto had a return on equity of 37.98% and a net margin of 7.76%. The firm’s quarterly revenue was down 8.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.39 EPS. On average, equities research analysts expect that Monsanto will post $4.46 EPS for the current fiscal year.
In other news, COO Brett D. Begemann sold 27,980 shares of the company’s stock in a transaction on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Michael K. Stern sold 12,797 shares of the company’s stock in a transaction on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the transaction, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The disclosure for this sale can be found here. Insiders own 0.88% of the company’s stock.
Several institutional investors have recently bought and sold shares of the company. South Dakota Investment Council bought a new position in Monsanto during the second quarter worth $1,551,000. Dorsey & Whitney Trust CO LLC bought a new position in Monsanto during the second quarter worth $215,000. Bank of Nova Scotia boosted its position in Monsanto by 6.4% in the second quarter. Bank of Nova Scotia now owns 8,794 shares of the company’s stock worth $909,000 after buying an additional 530 shares during the period. CNA Financial Corp bought a new position in Monsanto during the second quarter worth $714,000. Finally, Trexquant Investment LP boosted its position in Monsanto by 20.4% in the second quarter. Trexquant Investment LP now owns 26,009 shares of the company’s stock worth $2,690,000 after buying an additional 4,409 shares during the period. 79.06% of the stock is currently owned by institutional investors and hedge funds.
Several analysts have recently weighed in on the stock. S&P Equity Research restated a “positive” rating on shares of Monsanto in a research report on Thursday, September 15th. JPMorgan Chase & Co. restated a “hold” rating on shares of Monsanto in a research report on Thursday, June 30th. Zacks Investment Research downgraded shares of Monsanto from a “hold” rating to a “sell” rating in a research report on Friday, July 1st. Vetr upgraded shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $117.09 price objective for the company in a research report on Wednesday, August 3rd. Finally, Jefferies Group restated a “buy” rating on shares of Monsanto in a research report on Wednesday, June 29th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. Monsanto has an average rating of “Buy” and a consensus price target of $114.31.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.